- $1.31bn
- $1.73bn
- $860.49m
- 73
- 44
- 98
- 82
2019 December 31st | 2020 December 31st | 2021 December 31st | R2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 753 | 662 | 751 | 669 | 860 |
Cost of Revenue | |||||
Gross Profit | 83.8 | 75.4 | 43.6 | 73 | 110 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 692 | 648 | 729 | 616 | 772 |
Operating Profit | 60.3 | 13.9 | 21.5 | 53.6 | 88 |
Total Net Non Operating Interest Income / Expense | |||||
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | 46.4 | 0.427 | 9.45 | 35.7 | 56.9 |
Provision for Income Taxes | |||||
Net Income After Taxes | 37 | -5.17 | 7.97 | 26.7 | 43.2 |
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 37 | -5.17 | 7.97 | 28.1 | 39.1 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 37 | -5.17 | 7.97 | 28.1 | 39.1 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 3.35 | 1.94 | 0.666 | 2.08 | 3.06 |
Dividends per Share |